Identification of One BOCR Mutation and Five NF1 Mutations in Male Patients with Neurofibromatosis Type 1 and Congenital Pseudarthrosis of the Tibia

Neurofibromatosis type1 (NF1) is an autosomal dominant disorder caused by mutations in the NF1gene. Although congenital pseudarthrosis of the tibia (CPT) has frequently been associated with NF1, the underlying molecular mechanism of CPT in these NF1 patients is yet ill-understood. The aim of the present study was to detect NF1 mutations from genomic DNA and to harbor variants associated with CPT in NF1 patients. Whole-exome sequencing was first carried out with samples from two patients with CPT in one NF1 family, and a novel mutation c.2324A>G (p.E775G) in NF1 gene was identified. Additionally, a missense variant c.455C>T (p.P152L) in BCOR gene completely co-segregated with the CPT phenotype within this family. Subsequently, NF1 and NF2 genes in four other unrelated patients with both NF1 and CPT were screened using targeted sequencing. Four mutations in NF1 gene, including two known mutations (c.2288T>C/p.L763P, c.574 C>T/p.R192*) and two novel mutations (c.768delT/p.F256Lfs*25, c.2229_2230delTG/ p.V744Qfs*23) were detected. Further study confirmed that CPT was present in NF1 families, and NF1 mutations were closely associated with these complex phenotypes. Moreover, the data from the current study indicated that male gender might be a susceptibility factor for CPT in NF1. Therefore, we speculated that BCOR variants might be related to CPT phenotype among male NF1 patients.

[1]  Van Royen Kjell,et al.  Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia , 2016, European Journal of Pediatrics.

[2]  R. Margraf,et al.  Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1 , 2015, Journal of Medical Genetics.

[3]  C. Wise,et al.  Neurofibromin Deficiency‐Associated Transcriptional Dysregulation Suggests a Novel Therapy for Tibial Pseudoarthrosis in NF1 , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Juan Du,et al.  Demethylation of Epiregulin Gene by Histone Demethylase FBXL11 and BCL6 Corepressor Inhibits Osteo/dentinogenic Differentiation , 2013, Stem cells.

[5]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[6]  M. C. Valero,et al.  A highly sensitive genetic protocol to detect NF1 mutations. , 2011, The Journal of molecular diagnostics : JMD.

[7]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[8]  Guoping Fan,et al.  BCOR regulates mesenchymal stem cell function by epigenetic mechanisms , 2009, Nature Cell Biology.

[9]  J. Koivunen,et al.  Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression. , 2009, Bone.

[10]  Michael A Babcock,et al.  Neurofibromatosis Type 1 Revisited , 2009, Pediatrics.

[11]  C. Chung,et al.  Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. , 2008, The Journal of bone and joint surgery. American volume.

[12]  J. Carey,et al.  Double inactivation of NF1 in tibial pseudarthrosis. , 2006, American journal of human genetics.

[13]  L. Füzesi,et al.  Vascular changes in the periosteum of congenital pseudarthrosis of the tibia. , 2005, Pathology, research and practice.

[14]  B. Dallapiccola,et al.  Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1 , 2004, Human mutation.

[15]  L. Biesecker,et al.  Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR , 2004, Nature Genetics.

[16]  E. Verdin,et al.  BCoR, a novel corepressor involved in BCL-6 repression. , 2000, Genes & development.

[17]  P. Nürnberg,et al.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.

[18]  S. Wientroub,et al.  Congenital Pseudarthrosis of the Tibia: History, Etiology, Classification, and Epidemiologic Data , 2000, Journal of pediatric orthopedics. Part B.

[19]  S. Wientroub,et al.  Pathology of Bone Lesions Associated With Congenital Pseudarthrosis of the Leg , 2000, Journal of pediatric orthopedics. Part B.

[20]  T. Nagase,et al.  Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 2000, DNA research : an international journal for rapid publication of reports on genes and genomes.

[21]  D. Viskochil In search of the Holy Grail: NF1 mutation analysis and genotype phenotype correlation , 1999, Genetics in Medicine.

[22]  A. Crawford,et al.  Neurofibromatosis in children: the role of the orthopaedist. , 1999, The Journal of the American Academy of Orthopaedic Surgeons.

[23]  R. Tenconi,et al.  Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. , 1999, American journal of medical genetics.

[24]  J. Friedman,et al.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. , 1997, American journal of medical genetics.

[25]  P S Harper,et al.  Molecular genetics of neurofibromatosis type 1 (NF1). , 1996, Journal of medical genetics.

[26]  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.